The BALANCE program was intended to cover weight-loss drugs for Medicaid beneficiaries, but is delayed. A new solution with ...

Without big Medicare insurers, the future of program to cover popular obesity drugs had been in question.

The Centers for Medicare and Medicaid Services (CMS) and the U.S. Food and Drug Administration (FDA) announced on Thursday ...

The federal government scrapped a plan to have health insurance companies fund coverage of obesity drugs for seniors, opting instead to pay for the medicine with taxpayer dollars through the ...

By Mariam Sunny April 22 (Reuters) - A delay in a Medicare pilot to cover obesity drugs due to health insurers' hesitation to ...

In a first, the federal government is allowing certain hemp products to be used as treatments for people on Medicare. The new ...

Certain breakthrough-designated medical devices that receive market authorization will become eligible for Medicare coverage ...

The Trump administration announced that it is indefinitely delaying the implementation of the Medicare Part D portion of the ...

The Trump administration’s Medicare pilot program to cover GLP-1 weight-loss drugs, known as BALANCE, has been delayed due to insufficient insurer participation. A temporary bridge program will start ...

Medicare delayed a plan to make insurance companies cover GLP-1 drugs Wegovy and Zepbound. Instead, Medicare will cover the ...

The US Government will now pick up the cost of weight loss drugs offered through the Medicare GLP-1 Bridge scheme until 31 ...